One publication from the past week:

• Accounting for Intergenerational Cascade Testing in Economic Evaluations of Clinical Genomics: A Scoping Review | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• The effect of rapid exome sequencing on downstream health care utilization for infants with suspected genetic disorders in an intensive care unit | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Three publications from the past week:

• Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use | link
• Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective | link
• A new forum to discuss health economics and genomics in South Africa | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Factors that impact on women’s decision-making around prenatal genomic tests: An international discrete choice survey | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Should Whole Genome Sequencing be Publicly Funded for Everyone as a Matter of Healthcare Justice? | link
• Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Three publications from the past three weeks:

• Analyzing Precision Medicine Utilization with Real-World Data: A Scoping Review | link
• Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions | link
• Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Development of an optimized and generic cost-utility model for analyzing genome-guided treatment data | link
• Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Five publications from the past week:

• The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis | link
• Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access | link
• Medical costs of children admitted to the neonatal intensive care unit: The role and possible economic impact of WES in early diagnosis | link
• Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States | link
• Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Two publications from the past week:

• Defining a Core Data Set for the Economic Evaluation of Precision Oncology | link
• Trio genome sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

One publication from the past week:

• Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.